Parikh P M, Gupta S, Dawood S, Rugo H, Bhattacharyya G S, Agarwal A, Chacko R, Sahoo T P, Babu G, Agarwal S, Munshi A, Goswami C, Smruti B K, Bondarde S, Desai C, Rajappa S, Somani N, Singh M, Nimmagadda R, Pavitran K, Mehta A, Parmar V, Desai S, Nair R, Doval D
On behalf of Breast Cancer Expert Group of Indian Cooperative Oncology Network (ICON Trust), .
Indian J Cancer. 2014 Jan-Mar;51(1):73-9. doi: 10.4103/0019-509X.134650.
The management of hormone receptor-positive Her2-negative breast cancer patients with advanced or metastatic disease is a common problem in India and other countries in this region. This expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.
对于激素受体阳性、人表皮生长因子受体2阴性的晚期或转移性乳腺癌患者的管理，在印度及该地区的其他国家都是一个常见问题。该专家小组利用已发表文献的数据、实践经验以及一大批学术肿瘤学家的意见，得出了可供社区肿瘤学家使用的实用共识性建议。
